In Brief: Perrigo
This article was originally published in The Tan Sheet
Perrigo: FDA approves Perrigo's doxylamine succinate tablets, 25 mg. The product will be the second private label version of Pfizer's Unisom. Copley received approval for its version in February 1988...
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC